News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
244 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18311)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (164)
2 (249)
3 (156)
5 (7)
6 (230)
7 (240)
8 (320)
9 (291)
10 (99)
11 (2)
12 (4)
13 (247)
14 (235)
15 (231)
16 (238)
17 (128)
18 (5)
19 (4)
20 (183)
21 (221)
22 (223)
23 (239)
24 (116)
25 (4)
26 (4)
27 (246)
28 (244)
29 (262)
30 (310)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Biotech Bay
New 6-year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in Relapsing Multiple Sclerosis
Post-hoc analysis from 6 years of Phase III open-label extension studies showed Ocrevus treatment reduced the risk of needing a walking aid (EDSS≥6) by 49% in relapsing multiple sclerosis (RMS) patients compared with patients who switched from interferon beta-1a two years later
April 28, 2020
·
11 min read
Deals
Hansa Biopharma Interim Report Jan-Mar 2020. EMA Process on Track; an Opinion From the CHMP is Expected in the Second Quarter 2020
A formal adoption of outstanding questions, incl. definition of patients and design of the post approval study, expected at the CHMP April session
April 28, 2020
·
4 min read
Continued lack of PPE and testing, high sources of anxiety for physicians, new CMA poll says
The majority of physicians are feeling anxious about the pandemic and say that having more PPE and increasing testing would go a long way to help ease that anxiety, says a new poll by the Canadian Medical Association.
April 28, 2020
·
2 min read
BioMidwest
First Healthcare-Associated Infection Reduction Tied to Use of 90-Day Antimicrobial Coating, Study Indicates
Always-On™ surface coating demonstrates first correlation of sustained environmental bioburden reduction and 36% Healthcare-Associated Infection (HAI) declines
April 28, 2020
·
2 min read
Previous
25 of 25